Molecular Imaging

Molecular Imaging

Molecular Imaging

September 24, 2014 — GE Healthcare announced U.S. Food and Drug Administration (FDA) 510(k) clearance of its Discovery IQ PET/CT (positron emission tomography/computed tomography) system.

Patients with advanced breast cancer that may have spread to their lymph nodes could benefit from a more robust dose of a molecular imaging agent called Tc-99m filtered sulfur colloid when undergoing lymphoscintigraphy, a functional imaging techni...

The past year saw the release of several new, innovative technologies to improve nuclear imaging in both positron emission tomography (PET) and single-photon emission computed tomography (SPECT). 

GE Healthcare received U.S. Food and Drug Administration (FDA) 510(k) clearance of its Q.Clear technology, which is designed to provide up to two times improvement in both quantitative accuracy and image quality in PET/CT imaging. 

Nuclear imaging, Clinical trial/study, ADHA, 3-D SPECT imaging
A recently published study from Toronto, Canada found that patients who utilized 3-D SPECT were able to get a clearer diagnosis of ADHD, which is the...
Nuclear imaging, PET/CT, Clinical Trial/Study, RSNA 2014
Hybrid imaging with positron emission tomography and computed tomography (PET/CT) in the pituitary region of the brain is a promising tool for differentiating...
A novel study demonstrates the potential of a novel molecular imaging drug to detect and visualize early prostate cancer in soft tissue, lymph nodes and bone....
A study from Massachusetts General Hospital (MGH) investigators has identified for the first time changes in the metabolic activity of a key brain region in...
Siemens Healthcare's Symbia Evo Excel SPECT (single-photon emission computed tomography) system, a new version of the company’s Symbia E
Siemens Healthcare has introduced its xSPECT system that combines the high sensitivity of single-photon emission computed tomography (...
The PosiRx 3000-Series is Positron Corp.'s latest pharmacy automation systems. The PosiRx 3000-Series are the first systems to...
Nuclear Medicine Information Systems LLC (NMIS) and BioDose LLC have been renamed and rebranded as ec2 Software Solutions. The two...

Articles

Navidea Biopharmaceuticals, Inc. announced that the U.S. Food and Drug Administration (FDA) has approved the Supplemental New Drug Application (sNDA) for...
Remember the race to map the human genome, when the widest international collaboration in history went up against the efforts of a private corporation, Celera...
August 5, 2014 — GE Healthcare announced the first integrated, simultaneous, time-of-flight (TOF) capable, whole-body Signa PET/MR (positron emission...
The Society of Nuclear Medicine and Molecular Imaging (SNMMI) recently held its annual meeting in St. Louis. It provided an in-depth review of molecular...

Video Center

There were a few intriguing technology trends at the Radiological Society of North America (RSNA)...
10 hours 39 min ago
All major technology advances in the world of radiology and imaging are unveiled or highlighted at...
6 weeks 3 days ago
Remember the race to map the human genome, when the widest international collaboration in history...
11 weeks 10 hours ago
The CME webinar "State of the Art in MRI Pediatric Brain Perfusion Imaging" will educate participants in the state of the art clinical and emerging...
This webinar discusses why contemporary adult cardiac interventions require significant ionizing radiation with potential health risks to both the patient and...
The webinar "Any Image, Anywhere" explains the new ways radiologists and clinicians can boost productivity, optimize scarce resources, and connect their...